Sun Pharma’s market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013. The country’s leading drug maker......
'The failures of private businessmen have set back the process of market-oriented reform, though that is the only way forward,' argues T N Ninan. Illustration: Uttam Ghosh/Rediff.com It used to be......
Combined net profit estimated to grow 14.6% year-on-year, against a 5.7% decline in the Dec 2015 quarter Equity investors can expect a better show by the country's top listed companies during the......
* Dinesh Thakur famous for exposing Ranbaxy safety problems* Bringing public interest suit against health ministry, regulator* The suit claims lax regulation, inadequate pursuit of breaches* Suit......
A majority of India's billionaires gained wealth in the last one year despite the stock market decline and they continued to splurge on life's luxuries. Image: Reliance Industries chairman Mukesh......